Trimel Pharmaceuticals Announces Positive Phase II Results for Tefina™
May 28, 2014
Women treated with Tefina™ 0.6 mg reported a
statistically significant increase in orgasms versus placebo
TORONTO (May 28, 2014) – Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.